Deciphering the pharmacological mechanisms of Shenlingbaizhu formula in antibiotic-associated diarrhea treatment: Network pharmacological analysis and experimental validation

小桶 计算生物学 交互网络 体内 基因本体论 基因 PI3K/AKT/mTOR通路 药理学 化学 生物信息学 信号转导 生物化学 生物 基因表达 遗传学
作者
Yan Chen,Xiangmei Meng,Haocheng Zheng,Yixiao Gu,Wanhong Zhu,Sici Wang,Jie Lin,Tao Li,Mengting Liao,Yuhang Li,Shuzhen Guo,Xia Ding
出处
期刊:Journal of Ethnopharmacology [Elsevier BV]
卷期号:329: 118129-118129 被引量:6
标识
DOI:10.1016/j.jep.2024.118129
摘要

Shenlingbaizhu (SLBZ) formula, a classical traditional Chinese medicinal (TCM) formula, has been widely used for treating antibiotic-associated diarrhea (AAD). However, the underlying pharmacological mechanisms have not yet been investigated thoroughly. To explore the remission mechanism of SLBZ in the treatment of AAD, we conducted network pharmacological analysis and experimental validation in vitro and in vivo. In this study, the main compounds of SLBZ were identified by ultra-high-performance liquid chromatography-mass spectroscopy (UHPLC-MS) and online databases. The targets of the active components and AAD-related targets were predicted by network pharmacology, and the potential targets of SLBZ against AAD were obtained. Then the core targets were recognized after Protein-Protein Interaction (PPI) analysis. Based on these, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway analyses were conducted, and the key pathway was screened. Subsequently, molecular docking was performed using Auto Dock Vina to find the key components that played a crucial role in that pathway. Molecular dynamics simulation was performed by Gromacs software to detect the binding mode. Finally, the results were confirmed by in vitro and in vivo experiments. A total of 66 active ingredients of SLBZ were detected by UHPLC-MS, and 128 active ingredients were screened out by network pharmacological analysis. Additionally, 935 drug targets and 1686 AAD-related targets were obtained. Seventy-eight intersected genes were selected as potential therapeutic targets and 19 genes were excavated as core targets. Enrichment analysis revealed PI3K-AKT signaling pathway was the key pathway in SLBZ against AAD. Topological analysis further revealed that JAK2, MTOR, TLR4, and SYK were the key targets affected by SLBZ on the PI3K-AKT pathway, and 52 components of SLBZ were associated with them. Molecular docking and dynamics simulation revealed strong binding affinities between MTOR and diosgenin. Subsequently, after SLBZ treatment, the expression levels of JAK2, MTOR, TLR4, and SYK were found significantly upregulated in the AAD model rats (p < 0.05). The cell experiment further validated the good binding ability between MTOR and diosgenin. We demonstrate that the therapeutic effect of SLBZ on AAD was achieved in part by inhibiting the PI3K-AKT pathway.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
周周周发布了新的文献求助10
2秒前
lunarseven发布了新的文献求助30
4秒前
Chain发布了新的文献求助10
4秒前
在水一方的应助被dit采纳,获得10
4秒前
4秒前
fighting完成签到 ,获得积分10
4秒前
淡定的醉香完成签到,获得积分10
5秒前
河堤完成签到 ,获得积分10
6秒前
6秒前
6秒前
6秒前
阿巴吧完成签到 ,获得积分10
6秒前
7秒前
zo完成签到,获得积分20
8秒前
10秒前
10秒前
洁净雅彤发布了新的文献求助10
11秒前
平淡远航完成签到,获得积分10
11秒前
所所的应助被开心德地采纳,获得10
11秒前
JackieLiu的应助被简单亦寒采纳,获得30
12秒前
12秒前
泥头车完成签到,获得积分10
12秒前
liy发布了新的文献求助30
12秒前
12秒前
12秒前
13秒前
Lee完成签到,获得积分10
13秒前
molihuakai的应助被好吃懒做采纳,获得10
13秒前
猪猪侠完成签到,获得积分10
13秒前
火的信仰完成签到,获得积分10
14秒前
小回忆完成签到,获得积分10
15秒前
bkagyin的应助被小宇采纳,获得10
16秒前
16秒前
16秒前
16秒前
16秒前
落子无悔关注了科研通微信公众号
17秒前
钪锵玫瑰完成签到 ,获得积分10
17秒前
弦越的应助被吕培森采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188451
求助须知:如何正确求助?哪些是违规求助? 9576286
关于积分的说明 21846376
捐赠科研通 7786514
什么是DOI,文献DOI怎么找? 3435343
关于科研通互助平台的介绍 2559618
邀请新用户注册赠送积分活动 2482322